Objectives
"1. To review the latest Olumiant real world evidence and demonstrate the consistency of results between this and the clinical evidence.
2. To discuss why Olumiant should be used earlier in the treatment pathway and is the perfect molecule to implement a treat to target approach.
3. To agree that Olumiant should be a good contender for JAKI of choice.
This Course For :
Physician
( Rheumatology )
Resident / Fellow
( Rheumatology )
Speaker
Prof. Peter C Taylor
Oxford, UK
Prof. Mart van de Laar
Twente, The Netherlands
Professor Rieke Alten
Berlin, Germany
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
30 Jan 2024 To 30 Jan 2024 -
12:00 PM To 01:00 PM 
Certificate Available 
Online Click Here
- 50
Add to Calendar
01/30/2024 12:00 PM
01/30/2024 01:00 PM
Asia/ Riyadh
Should Olumiant be the JAKi of choice in rheumatoid arthritis? A review of the evidence
Should Olumiant be the JAKi of choice in rheumatoid arthritis? A review of the evidence
https://medicalacademy.org/portal/event/view/2116
